Trial intelligence / Profile preview

Effects of mexiletine and lacosamide on nerve excitability in healthy volunteers

NL-OMON25429Not yet recruiting

Sponsor
Centre for Human Drug Research
Start
Aug 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Trial of mexiletine and lacosamide (3 arms), sponsored by Centre for Human Drug Research. Primary endpoint: Nerve excitability threshold endpoints. Planned start Aug 2019; status: not yet recruiting.

02

Drugs

mexiletinelacosamide

Beyond the preview

Go deeper on NL-OMON25429.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25429.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call